Commerzbank Analysts Give Compugroup Medical (COP) a €53.00 Price Target

Commerzbank set a €53.00 ($61.63) target price on Compugroup Medical (ETR:COP) in a report released on Thursday morning. The brokerage currently has a buy rating on the stock.

A number of other equities analysts have also recently issued reports on COP. Baader Bank set a €46.00 ($53.49) price objective on shares of Compugroup Medical and gave the company a neutral rating in a research note on Thursday, August 9th. HSBC set a €60.00 ($69.77) price objective on shares of Compugroup Medical and gave the company a buy rating in a research note on Tuesday, October 30th. Berenberg Bank set a €49.00 ($56.98) price objective on shares of Compugroup Medical and gave the company a neutral rating in a research note on Monday, July 16th. Warburg Research set a €53.50 ($62.21) price objective on shares of Compugroup Medical and gave the company a buy rating in a research note on Monday, October 22nd. Finally, Deutsche Bank set a €62.00 ($72.09) price objective on shares of Compugroup Medical and gave the company a buy rating in a research note on Tuesday, August 14th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the stock. Compugroup Medical has a consensus rating of Hold and an average target price of €51.79 ($60.22).

COP stock traded down €1.96 ($2.28) during midday trading on Thursday, reaching €46.14 ($53.65). The company’s stock had a trading volume of 99,623 shares, compared to its average volume of 68,245. Compugroup Medical has a 52 week low of €40.10 ($46.63) and a 52 week high of €60.30 ($70.12).

About Compugroup Medical

CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks.

Recommended Story: NASDAQ

Analyst Recommendations for Compugroup Medical (ETR:COP)

Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply